Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)

Acta Oncol. 2013 Nov;52(8):1786-8. doi: 10.3109/0284186X.2013.786839. Epub 2013 Apr 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Immunotherapy*
  • Ipilimumab
  • Melanoma / drug therapy*
  • Melanoma / immunology
  • Melanoma / secondary
  • Neoplasm Staging
  • Netherlands
  • Prognosis
  • Retrospective Studies
  • Survival Rate
  • Uveal Neoplasms / drug therapy*
  • Uveal Neoplasms / immunology
  • Uveal Neoplasms / secondary

Substances

  • Antibodies, Monoclonal
  • Ipilimumab

Supplementary concepts

  • Uveal melanoma